Cellosaurus OKT 3 (CVCL_2665)
| Cell line name | OKT 3 |
|---|---|
| Synonyms | OKT3 |
| Accession | CVCL_2665 |
| Resource Identification Initiative | To cite this cell line use: OKT 3 (RRID:CVCL_2665) |
| Comments | Group: Patented cell line. Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8001. Biotechnology: The monoclonal antibody produced by this hybridoma was used as an immunosuppressant drug under the name Muromonab-CD3 (Orthoclone OKT3). Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized teplizumab (MGA031) therapeutic antibody. Monoclonal antibody isotype: IgG2a. Monoclonal antibody target: UniProtKB; P07766; Human CD3E. Anecdotal: OKT3 was the first monoclonal antibody to be approved for clinical use in humans. |
| Species of origin | Mus musculus (Mouse) (NCBI Taxonomy: 10090) |
| Hierarchy | Parent: CVCL_3412 (P3X63Ag8U.1) |
| Category | Hybridoma |
| Publications | PubMed=314668; DOI=10.1126/science.314668 Patent=US4361549 DOI=10.1007/978-1-4899-1236-7_4 |
| Cross-references | |
| Cell line collections (Providers) | ATCC; CRL-8001
BCRC; 60154 CLS; 300499 ECACC; 86022706 IZSLER; BS Hy 12 NCBI_Iran; H104 TKG; TKG 0235 - Discontinued |
| Cell line databases/resources | CLO; CLO_0008252
CLDB; cl5239 CCRID; 3101ETCHYB58 |
| Biological sample resources | ABCD; ABCD_AC852 |
| Encyclopedic resources | Wikidata; Q54931950 |
| Entry history | |
| Entry creation | 04-Apr-2012 |
| Last entry update | 14-Aug-2025 |
| Version number | 15 |